University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

Simple item page
dc.contributor.authorWhyte, Claire S.
dc.contributor.authorMorrow, Gael B.
dc.contributor.authorMitchell, Joanne L.
dc.contributor.authorChowdary, Pratima
dc.contributor.authorMutch, Nicola J.
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Cardiometabolic Diseaseen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cardiovascular and Diabetes Centreen
dc.date.accessioned2020-07-06T06:45:03Z
dc.date.available2020-07-06T06:45:03Z
dc.date.issued2020-07
dc.descriptionOpen Access via the Wiley Jisc Agreement With thanks to Wai-Lum Sum from Medical Illustration at the University of Aberdeen with help in compiling figure 2 of the manuscript. British Heart Foundation (GrantNumber(s): FS/11/2/28579, PG/15/82/31721)en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent821350
dc.identifier161952080
dc.identifierc189dc04-8aee-4e1b-bb87-f90c7734e2e8
dc.identifier85084616473
dc.identifier32329246
dc.identifier000537272200001
dc.identifier32329246
dc.identifier.citationWhyte, C S, Morrow, G B, Mitchell, J L, Chowdary, P & Mutch, N J 2020, 'Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19', Journal of Thrombosis and Haemostasis, vol. 18, no. 7, pp. 1548-1555. https://doi.org/10.1111/jth.14872en
dc.identifier.doi10.1111/jth.14872
dc.identifier.iss7en
dc.identifier.issn1538-7933
dc.identifier.otherPubMedCentral: PMC7264738
dc.identifier.otherORCID: /0000-0001-8127-6102/work/101050691
dc.identifier.otherORCID: /0000-0001-9299-6754/work/116417845
dc.identifier.otherORCID: /0000-0002-7452-0813/work/169538858
dc.identifier.urihttps://hdl.handle.net/2164/14655
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85084616473&partnerID=8YFLogxKen
dc.identifier.vol18en
dc.language.isoeng
dc.relation.ispartofJournal of Thrombosis and Haemostasisen
dc.subjectFibrinolysisen
dc.subjectFibrinen
dc.subjectPlasminogen Activator Inhibitor 1en
dc.subjectTissue plasminogen activatoren
dc.subjectRespiratory distress syndrome (Adult)en
dc.subjectSARS virusen
dc.subjectFACTOR XAen
dc.subjecttissue plasminogen activatoren
dc.subjectMACROPHAGEen
dc.subjectACUTE LUNG INJURYen
dc.subjectPLASMINOGEN-ACTIVATOR INHIBITOR-1en
dc.subjectrespiratory distress syndrome (adult)en
dc.subjectPNEUMONIAen
dc.subjectplasminogen activator inhibitor 1en
dc.subjectINTERLEUKIN-8en
dc.subjectfibrinolysisen
dc.subjectELEVATED LEVELSen
dc.subjectCOAGULATIONen
dc.subjectfibrinen
dc.subjectEXPRESSIONen
dc.subjectTISSUE FACTORen
dc.subjectR Medicine (General)en
dc.subjectHematologyen
dc.subjectBritish Heart Foundationen
dc.subjectFS/11/2/28579en
dc.subjectPG/15/82/31721en
dc.subject.lccR1en
dc.titleFibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Whyte_etal_jth_Fibrinolytic_abnormalities_VOR.pdf
Size:
802.1 KB
Format:
Adobe Portable Document Format
Download

Collections

All research